Assignee
X4 PHARMACEUTICALS AUSTRIA GMBH
AT·2 granted patents·2 pending applications·9 citations·filing 2015–2022
Top patents by PatentIndex Score
4 records- 0192US10940191B2MDR E. coli specific antibodyX4 PHARMACEUTICALS AUSTRIA GMBH·Filed 2018·Granted Mar 9, 2021·9 cites·27 claims
- 0264US2023220055A1Antibodies targeting a galactan-based o-antigen of k. pneumoniaeX4 PHARMACEUTICALS AUSTRIA GMBH·Filed 2022·Application pending·0 cites
- 0351US2020339668A1Klebsiella pneumoniae o3 specific antibodiesX4 PHARMACEUTICALS AUSTRIA GMBH·Filed 2020·Application pending·0 cites
- 0450US11466074B2Antibodies targeting a galactan-based O-antigen of K. pneumoniaeX4 PHARMACEUTICALS AUSTRIA GMBH·Filed 2015·Granted Oct 11, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when X4 PHARMACEUTICALS AUSTRIA GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →